Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06620055

Development of an Artificial Intelligence Model for Optimising Therapy in Gliomas Gliomas

Sponsor: Centro di Riferimento Oncologico - Aviano

View on ClinicalTrials.gov

Summary

Artificial intelligence (AI) undoubtedly represents the main tool currently available in the definition of complex algorithms and its use in the medical field is becoming increasingly strategic.As reported in the literature, it is increasingly difficult to find new therapeutic strategies for neoplasms, especially neurological ones. Molecular characterisation is therefore increasingly essential, as is the use of new predictive methods. With this in mind, the aim of this study is to assess, by means of AI algorithms applied to genomic data, in what percentage molecular alterations are susceptible to potential drug therapies, compared to the literature data that does not consider AI algorithms for this purpose.

Official title: Development of an Artificial Intelligence Model for Optimising Therapy in Gliomas

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

164

Start Date

2023-11-16

Completion Date

2028-11-16

Last Updated

2024-10-01

Healthy Volunteers

No

Conditions

Locations (3)

Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS

Aviano, Pordenone, Italy

IOV

Padova, Italy

Azienda Sanitaria Universitaria Friuli Centrale (ASUFC

Udine, Italy